| 421 | SHORTS, MARYDURHAM, NC · 27709 | RX SALES RESPIRATORY BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 422 | LANGELER, MARTINDURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 423 | PELLOQUIN, MARK J.DURHAM, NC · 27709 | VACCINES STRATEGIC ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 424 | HITCHCOCK, LISADURHAM, NC · 27709 | SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 425 | NORRIS, LISA KDURHAM, NC · 27709 | PRICING/REIMBURSEMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 426 | NEWMAN, LISA A.PHILADELPHIA, PA · 19112 | MANAGER, SPECIALTY ACCESS & REIMBURSEM · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 427 | PARKS, KEVIN R.ZEBULON, NC · 27597 | SITE ENGINEERING LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 428 | GUEDRY, KELLY PDURHAM, NC · 27709 | RX ACCOUNT MGMT RETAIL EXECUTIVE (SALE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 429 | STEFL, JOHNDURHAM, NC · 27709 | CIGNA ENTERPRISE MARKET ANALYTICS DIRE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 430 | BARONE, JESSICADURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 431 | CHACON, JAVIER F.DURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 432 | GROSSMANN, GLENN RUSSELLDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 433 | ADAMS, GRACE E.DURHAM, NC · 27709 | SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 434 | BROOKERD, DONNA RDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 435 | VIGGIANO, DOROTHY P.DURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 436 | THORNTON, EILEENBUFFALO GROVE, IL · 60089 | MARKETING & SALES EXECUTIVE · GLAXOSMITHKLINE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2025-05-15 | $9 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1902035FEC filing ↗ |
| 437 | RICE, DAVID F.DURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 438 | O'DONNELL, ANDREW JOHNDURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 439 | PRINCE, DEIDRE ADURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |
| 440 | DINGMAN, CONSTANCE K.DURHAM, NC · 27709 | RX SALES PRIMARY CARE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-05 | $9 | Primary (P) | Filing 1937874FEC filing ↗ |